B. 1. Hunder, G. Bloch, D. Michel, B. Stevens, M. Arend et al., The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis, Arthritis & Rheumatism, vol.33, issue.8, pp.1122-1130, 1990.
DOI : 10.7326/0003-4819-88-2-162

K. Ly, A. Régent, M. Tamby, and L. Mouthon, Pathogenesis of giant cell arteritis: More than just an inflammatory condition?, Autoimmunity Reviews, vol.9, issue.10, pp.635-680, 2010.
DOI : 10.1016/j.autrev.2010.05.002

URL : https://hal.archives-ouvertes.fr/hal-00597708

A. Brack, V. Martinez-taboada, A. Stanson, J. Goronzy, and C. Weyand, Disease pattern in cranial and large-vessel giant cell arteritis, Arthritis & Rheumatism, vol.122, issue.2, pp.311-318, 1999.
DOI : 10.7326/0003-4819-122-7-199504010-00004

K. Lensen, A. Voskuyl, E. Comans, C. Van-der-laken, and Y. Smulders, Extracranial giant cell arteritis: A narrative review, Neth J Med. 2016, vol.74, issue.5, pp.182-92

M. Gonzalez-gay, C. Garcia-porrua, J. Llorca, C. Gonzalez-louzao, and P. Rodriguez-ledo, Biopsy-negative giant cell arteritis: Clinical spectrum and predictive factors for positive temporal artery biopsy, Seminars in Arthritis and Rheumatism, vol.30, issue.4, pp.249-56, 2001.
DOI : 10.1053/sarh.2001.16650

R. Pla, A. , R. Urgell, J. , B. Gil et al., Proposal to decrease the number of negative temporal artery biopsies, Scandinavian Journal of Rheumatology, vol.36, issue.2, pp.111-119, 2007.

E. Quinn, D. Kearney, J. Kelly, C. Keohane, and H. Redmond, Temporal Artery Biopsy is not Required in all Cases of Suspected Giant Cell Arteritis, Annals of Vascular Surgery, vol.26, issue.5, pp.649-54
DOI : 10.1016/j.avsg.2011.10.009

P. Duhaut, L. Pinède, H. Bornet, S. Demolombe-ragué, C. Dumontet et al., Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease, Annals of the Rheumatic Diseases, vol.58, issue.6
DOI : 10.1136/ard.58.6.335

F. Muratore, T. Kermani, C. Crowson, A. Green, C. Salvarani et al., Large-vessel giant cell arteritis: a cohort study, Rheumatology, vol.54, issue.3, pp.463-70, 2015.
DOI : 10.1093/rheumatology/keu329

A. Arida, M. Kyprianou, M. Kanakis, and P. Sfikakis, The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis, BMC Musculoskeletal Disorders, vol.3, issue.3 Suppl 49, p.44, 2010.
DOI : 10.1038/ncprheum0377

A. Khan and B. Dasgupta, Imaging in Giant Cell Arteritis, Current Rheumatology Reports, vol.58, issue.8, p.52, 2015.
DOI : 10.1002/art.23699

W. Schmidt, H. Kraft, K. Vorpahl, L. Völker, and E. Gromnica-ihle, Color Duplex Ultrasonography in the Diagnosis of Temporal Arteritis, New England Journal of Medicine, vol.337, issue.19, pp.1336-1378, 1997.
DOI : 10.1056/NEJM199711063371902

M. Czihal, S. Zanker, A. Rademacher, F. Tatò, P. Kuhlencordt et al., Sonographic and clinical pattern of extracranial and cranial giant cell arteritis, Scandinavian Journal of Rheumatology, vol.533, issue.3, pp.231-237, 2012.
DOI : 10.1212/WNL.38.3.352

R. Luqmani, E. Lee, S. Singh, M. Gillett, W. Schmidt et al., Funding, Health Technology Assessment, vol.20, issue.90, 2016.
DOI : 10.3310/hta20900

M. Alba, A. García-martínez, S. Prieto-gonzález, I. Tavera-bahillo, M. Corbera-bellalta et al., Relapses in Patients With Giant Cell Arteritis, Medicine, vol.93, issue.5, 2014.
DOI : 10.1097/MD.0000000000000033

J. Filloy, Relapses and recurrences in giant cell arteritis: a population-based study of patients with biopsy-proven disease from northwestern Spain, Medicine, vol.90, issue.3, pp.186-93, 2011.

G. Restuccia, L. Boiardi, A. Cavazza, M. Catanoso, P. Macchioni et al., Flares in Biopsy-Proven Giant Cell Arteritis in Northern Italy, Medicine, vol.95, issue.19, pp.703-711, 2003.
DOI : 10.1097/MD.0000000000003524

B. Baslund, M. Helleberg, M. Faurschou, and N. Obel, Mortality in patients with giant cell arteritis, Rheumatology, vol.54, issue.1, pp.139-182
DOI : 10.1093/rheumatology/keu303

J. Schmidt, A. Smail, B. Roche, P. Gay, V. Salle et al., Incidence of Severe Infections and Infection-Related Mortality During the Course of Giant Cell Arteritis: A Multicenter, Prospective, Double-Cohort Study, Arthritis & Rheumatology, vol.282, issue.6, pp.1477-82
DOI : 10.1136/bmj.282.6260.269

C. Salvarani, F. Cantini, L. Boiardi, and G. Hunder, Polymyalgia Rheumatica and Giant-Cell Arteritis, New England Journal of Medicine, vol.347, issue.4, pp.261-71, 2002.
DOI : 10.1056/NEJMra011913

J. Hutchinson, Diseases of the arteries. Archive of Surgery London, p.323, 1890.

B. Horton, T. Magath, and G. Brown, An unddescribed form of arteritis of the temporal vessels, pp.700-701, 1932.

G. Jennings, M. Camb, and M. Lond, Arteritis of the temporal vessels. The Lancet, 1938.

J. Paviot, R. Chevallier, A. Guichard, and M. Damez, Algie sympathique cranio-faciale à type migraineux avec dilatation des artères temporales, au cours d'un rhumatisme cardiaque solitaire, pp.45-51, 1934.

B. Nc, W. Hp, and S. Rm, Treatment of temporal arteritis with adrenal corticosteroids; results in fifty-five cases in which lesion was proved at biopsy, J Am Med Assoc, vol.163, issue.10, pp.821-828, 1957.

M. Gonzalez-gay, T. Vazquez-rodriguez, M. Lopez-diaz, J. Miranda-filloy, C. Gonzalez-juanatey et al., Epidemiology of giant cell arteritis and polymyalgia rheumatica, Arthritis & Rheumatism, vol.29, issue.10, pp.611454-61, 2009.
DOI : 10.7326/0003-4819-120-12-199406150-00003

O. Espitia, M. Samson, L. Gallou, T. Connault, J. Landron et al., Comparison of idiopathic (isolated) aortitis and giant cell arteritis-related aortitis. A French retrospective multicenter study of 117 patients, Autoimmunity Reviews, vol.15, issue.6, pp.571-577
DOI : 10.1016/j.autrev.2016.02.016

URL : https://hal.archives-ouvertes.fr/hal-01278610

R. Talarico, L. Boiardi, N. Pipitone, A. Ascanio, C. Stagnaro et al., Isolated aortitis versus giant cell arteritis: are they really two sides of the same coin?, Clin Exp Rheumatol, 2014.

P. Elling, A. Olsson, and H. Elling, Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection, J Rheumatol, vol.23, issue.1, pp.112-121, 1996.

G. Haugeberg, K. Irgens, and R. Thomsen, No major differences in incidence of temporal arteritis in northern and western Norway compared with reports from southern Norway, Scandinavian Journal of Rheumatology, vol.33, issue.5, pp.318-327, 2003.
DOI : 10.1002/art.1780330810

I. Chaudhry, F. Shamsi, E. Elzaridi, Y. Arat, T. Bosley et al., Epidemiology of giant-cell arteritis in an Arab population: a 22-year study, British Journal of Ophthalmology, vol.91, issue.6, pp.715-723, 2007.
DOI : 10.1136/bjo.2006.108845

L. Pereira, M. Yoon, T. Hwang, J. Hong, K. Ray et al., Giant cell arteritis in Asians: a comparative study, British Journal of Ophthalmology, vol.95, issue.2, pp.214-220, 2011.
DOI : 10.1136/bjo.2009.177220

C. Smith, W. Fidler, and R. Pinals, The epidemiology of giant cell arteritis Report of a ten-year study in Shelby County, Tennessee. Arthritis Rheum, pp.1214-1223, 1983.

S. Chiappe, A. Aouba, M. Eb, G. Rey, A. Mahr et al., Mortalité associée à l'artérite à cellules géantes (Horton) en France pour la période, pp.1-2, 1980.

M. Bas-lando, G. Breuer, Y. Berkun, M. Mates, M. Sonnenblick et al., The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations, Clin Exp Rheumatol, vol.25, issue.1, pp.15-22, 2007.

E. Nordborg and C. Nordborg, Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment, Rheumatology, vol.42, issue.3, pp.413-434, 2003.
DOI : 10.1093/rheumatology/keg116

O. Pamuk, S. Dönmez, B. Karahan, G. Pamuk, and N. Cakir, Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data, Clin Exp Rheumatol, vol.27, issue.5, pp.830-833, 2009.

M. Gonzalez-gay, J. Miranda-filloy, M. Lopez-diaz, R. Perez-alvarez, C. Gonzalez-juanatey et al., Giant Cell Arteritis in Northwestern Spain, Medicine, vol.86, issue.2, pp.61-69, 2007.
DOI : 10.1097/md.0b013e31803d1764

C. Weyand, K. Hicok, G. Hunder, and J. Goronzy, The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule., Journal of Clinical Investigation, vol.90, issue.6, 1992.
DOI : 10.1172/JCI116125

M. Gonzalez-gay, A. Hajeer, A. Dababneh, C. Garcia-porrua, D. Mattey et al., IL- 6 promoter polymorphism at position -174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis, Clin Exp Rheumatol, vol.20, issue.2, pp.179-84, 2002.

F. Carmona, J. Martin, and M. Gonzalez-gay, Genetics of vasculitis, Current Opinion in Rheumatology, vol.27, issue.1, pp.10-17
DOI : 10.1097/BOR.0000000000000124

M. Gonzalez-gay, A. Hajeer, A. Dababneh, C. Garcia-porrua, M. Amoli et al., Corticotropin releasing hormone promoter polymorphisms in giant cell arteritis and polymyalgia rheumatica, Clin Exp Rheumatol, vol.20, issue.2, pp.133-141, 2002.

M. Gonzalez-gay, Genetic epidemiology. Giant cell arteritis and polymyalgia rheumatica, Arthritis Research, vol.3, issue.3, pp.154-161, 2001.
DOI : 10.1186/ar293

C. Salvarani, S. Gabriel, O. Fallon, W. Hunder, and G. , The Incidence of Giant Cell Arteritis in Olmsted County, Minnesota: Apparent Fluctuations in a Cyclic Pattern, Annals of Internal Medicine, vol.123, issue.3, pp.192-196, 1995.
DOI : 10.7326/0003-4819-123-3-199508010-00006

P. Duhaut, S. Bosshard, and J. Ducroix, Is giant cell arteritis an infectious disease? Biological and epidemiological evidence, Presse Med, pp.1403-1411, 2004.
DOI : 10.1016/s0755-4982(04)98939-7

C. Koening, B. Katz, J. Hernandez-rodriguez, M. Corbera-bellalta, M. Cid et al., Identification of a Burkholderia-Like Strain From Temporal Arteries of Subjects with Giant Cell Arteritis

M. Nagel, R. Cohrs, R. Mahalingam, M. Wellish, B. Forghani et al., The varicella zoster virus vasculopathies: Clinical, CSF, imaging, and virologic features, Neurology, vol.70, issue.11, pp.853-60, 2008.
DOI : 10.1212/01.wnl.0000304747.38502.e8

D. Gilden and M. Nagel, Varicella zoster virus and giant cell arteritis, Curr Opin Infect Dis, 2016.

R. Rhee, P. Grayson, P. Merkel, and G. Tomasson, Infections and the risk of incident giant cell arteritis: a population-based, case-control study. Annals of the Rheumatic Diseases, 2017.

W. Krupa, M. Dewan, M. Jeon, P. Kurtin, B. Younge et al., Trapping of Misdirected Dendritic Cells in the Granulomatous Lesions of Giant Cell Arteritis, The American Journal of Pathology, vol.161, issue.5, 2002.
DOI : 10.1016/S0002-9440(10)64458-6

O. Pryshchep, W. Ma-krupa, B. Younge, J. Goronzy, and C. Weyand, Vessel-specific Toll-like receptor profiles in human medium and large arteries. Circulation, pp.1276-84, 2008.

K. Ly, E. Liozon, A. Fauchais, E. Vidal, C. Weyand et al., Pathophysiology of giant cell arteritis.]. La Revue de Médecine Interne Medium-and large-vessel vasculitis, N Engl J Med, vol.56349, issue.2, pp.160-169, 2003.

M. Corbera-bellalta, E. Planas-rigol, E. Lozano, N. Terrades-garcía, M. Alba et al., Blocking interferon ?? reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis, Annals of the Rheumatic Diseases, vol.73, issue.6, pp.1177-86, 2016.
DOI : 10.1136/annrheumdis-2013-203322

M. Samson, S. Audia, J. Fraszczak, M. Trad, P. Ornetti et al., Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis, Arthritis & Rheumatism, vol.185, issue.11, pp.3788-98, 2012.
DOI : 10.4049/jimmunol.1001343

URL : https://hal.archives-ouvertes.fr/inserm-00799573

M. Kaiser, B. Younge, J. Björnsson, J. Goronzy, and C. Weyand, Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells, Am J Pathol, 1999.

M. Samson, K. Ly, B. Tournier, N. Janikashvili, M. Trad et al., Involvement and prognosis value of CD8 + T cells in giant cell arteritis, Journal of Autoimmunity, vol.72, pp.73-83, 2016.
DOI : 10.1016/j.jaut.2016.05.008

URL : https://hal.archives-ouvertes.fr/hal-01431809

G. Hoffman, Giant Cell Arteritis Ann Intern Med, pp.65-80, 2016.

C. Weyand and J. Goronzy, Clinical practice. Giant-cell arteritis and polymyalgia rheumatica, N Engl J Med Jul, vol.3371, issue.1, pp.50-57, 2014.

S. Prieto-gonzález, P. Arguis, A. García-martínez, G. Espígol-frigolé, I. Tavera-bahillo et al., Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography, Annals of the Rheumatic Diseases, vol.71, issue.7, 2012.
DOI : 10.1136/annrheumdis-2011-200865

D. Nuenninghoff, G. Hunder, T. Christianson, R. Mcclelland, and E. Matteson, Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: A population-based study over 50 years, Arthritis & Rheumatism, vol.282, issue.12, 2003.
DOI : 10.1002/art.11480

A. Mahr, A. Aouba, P. Richebé, and S. Gonzalez-chiappe, Épidémiologie et histoire naturelle de l'artérite à cellules géantes (Horton) La Revue de Médecine Interne, 2016.
DOI : 10.1016/j.revmed.2017.03.007

C. Dejaco, C. Duftner, F. Buttgereit, E. Matteson, and B. Dasgupta, The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease, Rheumatology, p.2017
DOI : 10.1093/rheumatology/kew273

M. Gonzalez-gay, M. Lopez-diaz, S. Barros, C. Garcia-porrua, A. Sanchez-andrade et al., Giant Cell Arteritis, Medicine, vol.84, issue.5, pp.277-90, 2005.
DOI : 10.1097/01.md.0000180043.19285.54

T. Kermani, J. Schmidt, C. Crowson, S. Ytterberg, G. Hunder et al., Utility of Erythrocyte Sedimentation Rate and C-Reactive Protein for the Diagnosis of Giant Cell Arteritis, Seminars in Arthritis and Rheumatism, vol.41, issue.6, pp.866-71
DOI : 10.1016/j.semarthrit.2011.10.005

T. Kermani, K. Warrington, D. Cuthbertson, S. Carette, G. Hoffman et al., Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study, J Rheumatol. 2015, vol.42, issue.7, pp.1213-1220

C. Weyand, J. Fulbright, G. Hunder, J. Evans, and J. Goronzy, Treatment of giant cell arteritis: Interleukin-6 as a biologic marker of disease activity, Arthritis & Rheumatism, vol.43, issue.5, pp.1041-1049, 2000.
DOI : 10.1002/1529-0131(200005)43:5<1041::AID-ANR12>3.0.CO;2-7

J. Narvaez, B. Bernad, D. Roig-vilaseca, C. García-gómez, C. Gómez-vaquero et al., Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis. Semin Arthritis Rheum, pp.13-22, 2007.

F. Karassa, M. Matsagas, W. Schmidt, and J. Ioannidis, Meta-Analysis: Test Performance of Ultrasonography for Giant-Cell Arteritis, Annals of Internal Medicine, vol.142, issue.5, pp.359-69, 2005.
DOI : 10.7326/0003-4819-142-5-200503010-00011

R. Taylor-gjevre, M. Vo, D. Shukla, and L. Resch, Temporal artery biopsy for giant cell arteritis, J Rheumatol, vol.32, issue.7, pp.1279-82, 2005.

G. Breuer, G. Nesher, and R. Nesher, Rate of Discordant Findings in Bilateral Temporal Artery Biopsy to Diagnose Giant Cell Arteritis, The Journal of Rheumatology, vol.36, issue.4, pp.794-800, 2009.
DOI : 10.3899/jrheum.080792

C. Davies and D. May, The role of temporal artery biopsies in giant cell arteritis, The Annals of The Royal College of Surgeons of England, vol.93, issue.1, pp.4-5, 2011.
DOI : 10.1308/003588411X12851639107476

S. Hall, S. Persellin, J. Lie, O. Brien, P. Kurland et al., The therapeutic impact of temporal artery biopsy. Lancet, pp.1217-1237, 1983.

V. Rodriguez-valverde, J. Sarabia, M. Gonzalez-gay, M. Figueroa, J. Armona et al., Risk Factors and Predictive Models of Giant Cell Arteritis in Polymyalgia Rheumatica, The American Journal of Medicine, vol.102, issue.4, pp.331-337, 1997.
DOI : 10.1016/S0002-9343(97)00117-4

G. Smetana and R. Shmerling, Does this patient have temporal arteritis? JAMA, pp.92-101, 2002.

A. García-martínez, P. Arguis, S. Prieto-gonzález, G. Espígol-frigolé, M. Alba et al., Prospective long term follow-up of a cohort of patients with giant cell arteritis screened for aortic structural damage (aneurysm or dilatation), Annals of the Rheumatic Diseases, vol.38, issue.suppl, 2014.
DOI : 10.3899/jrheum.110275

S. Prieto-gonzález, A. García-martínez, I. Tavera-bahillo, J. Hernández-rodríguez, J. Gutiérrez-chacoff et al., Effect of Glucocorticoid Treatment on Computed Tomography Angiography Detected Large-Vessel Inflammation in Giant-Cell Arteritis. A Prospective, Longitudinal Study, Medicine, vol.94, issue.5, p.486, 2015.
DOI : 10.1097/MD.0000000000000486

T. Klink, J. Geiger, M. Both, T. Ness, S. Heinzelmann et al., Giant Cell Arteritis: Diagnostic Accuracy of MR Imaging of Superficial Cranial Arteries in Initial Diagnosis???Results from a Multicenter Trial, Radiology, vol.273, issue.3, pp.844-52, 2014.
DOI : 10.1148/radiol.14140056

T. Bley, M. Uhl, J. Carew, M. Markl, D. Schmidt et al., Diagnostic Value of High-Resolution MR Imaging in Giant Cell Arteritis, American Journal of Neuroradiology, vol.28, issue.9, pp.1722-1729, 2007.
DOI : 10.3174/ajnr.A0638

M. Soussan, N. P. Schramm, C. Katsahian, S. Pop, G. Fain et al., Management of largevessel vasculitis with FDG-PET: a systematic literature review and meta-analysis, Medicine, 2015.

S. Janssen, E. Comans, A. Voskuyl, W. Wisselink, and Y. Smulders, Giant cell arteritis: heterogeneity in clinical presentation and imaging results. journal of vascular surgery, 2008.

D. Blockmans, T. Bley, and W. Schmidt, Imaging for large-vessel vasculitis, Current Opinion in Rheumatology, vol.21, issue.1, pp.19-28, 2009.
DOI : 10.1097/BOR.0b013e32831cec7b

M. Gonzalez-gay, R. Blanco, V. Rodriguez-valverde, V. Martinez-taboada, M. Delgado-rodriguez et al., Permanent visual loss and cerebrovascular accidents in giant cell arteritis: Predictors and response to treatment, Arthritis & Rheumatism, vol.40, issue.8, pp.1497-504, 1998.
DOI : 10.1002/art.1780400105

C. Salvarani, B. Della, C. Cimino, L. Macchioni, P. Formisano et al., Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis, Rheumatology, vol.48, issue.3, pp.250-253, 2009.
DOI : 10.1093/rheumatology/ken465

G. Nesher, Y. Berkun, M. Mates, M. Baras, A. Rubinow et al., Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis, Arthritis & Rheumatism, vol.20, issue.4, 2004.
DOI : 10.1016/S0002-9394(14)70999-7

P. Aiello, J. Trautmann, T. Mcphee, A. Kunselman, and G. Hunder, Visual Prognosis in Giant Cell Arteritis, Ophthalmology, vol.100, issue.4, pp.550-555, 1993.
DOI : 10.1016/S0161-6420(93)31608-8

E. Liozon, K. Ly, and P. Robert, [Ocular complications of giant cell arteritis.], Rev Med Interne, 2013.

B. Bienvenu, K. Ly, M. Lambert, C. Agard, M. André et al., Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA), La Revue de M??decine Interne, vol.37, issue.3
DOI : 10.1016/j.revmed.2015.12.015

M. Hill, S. Szefler, B. Ball, M. Bartoszek, and A. Brenner, Monitoring glucocorticoid therapy: A pharmacokinetic approach, Clinical Pharmacology and Therapeutics, vol.48, issue.4, pp.390-398, 1990.
DOI : 10.1038/clpt.1990.167

G. Delecoeuillerie, P. Joly, A. Cohen-de-lara, and J. Paolaggi, Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients)., Annals of the Rheumatic Diseases, vol.47, issue.9, pp.733-742, 1988.
DOI : 10.1136/ard.47.9.733

I. Lundberg and E. Hedfors, Restricted dose and duration of corticosteroid treatment in patients with polymyalgia rheumatica and temporal arteritis, J Rheumatol, vol.17, issue.10, pp.1340-1345, 1990.

V. Kyle and B. Hazleman, Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects., Annals of the Rheumatic Diseases, vol.48, issue.8, 1989.
DOI : 10.1136/ard.48.8.662

M. Mazlumzadeh, G. Hunder, K. Easley, K. Calamia, E. Matteson et al., Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: A double-blind, placebo-controlled, randomized prospective clinical trial, Arthritis & Rheumatism, vol.43, issue.10, 2006.
DOI : 10.1016/S0002-9440(10)65175-9

G. Hoffman, M. Cid, D. Hellmann, L. Guillevin, J. Stone et al., A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis, Arthritis & Rheumatism, vol.127, issue.Suppl, pp.1309-1327, 2002.
DOI : 10.7326/0003-4819-127-5-199709010-00003

R. Seror, G. Baron, E. Hachulla, M. Debandt, C. Larroche et al., Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial, Annals of the Rheumatic Diseases, vol.73, issue.12, pp.2074-81, 2014.
DOI : 10.1136/annrheumdis-2013-203586

P. Chevalet, J. Barrier, P. Pottier, G. Magadur-joly, M. Pottier et al., A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients, J Rheumatol, vol.27, issue.6, pp.1484-91, 2000.

S. Hayreh, B. Zimmerman, and R. Kardon, Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature, Acta Ophthalmologica Scandinavica, vol.1, issue.4, 2002.
DOI : 10.1111/j.1755-3768.1994.tb04696.x

C. Chan, M. Paine, O. Day, and J. , Steroid management in giant cell arteritis, British Journal of Ophthalmology, vol.85, issue.9, 2001.
DOI : 10.1136/bjo.85.9.1061

H. De-boysson, E. Liozon, M. Lambert, A. Dumont, J. Boutemy et al., Giant-Cell Arteritis: Do We Treat Patients with Large-Vessel Involvement Differently?, The American Journal of Medicine, vol.130, issue.8, 2017.
DOI : 10.1016/j.amjmed.2017.03.054

C. Assie, A. Janvresse, D. Plissonnier, H. Lévesque, and M. I. , Long-Term Follow-Up of Upper and Lower Extremity Vasculitis Related to Giant Cell Arteritis, Medicine, vol.90, issue.1, 2011.
DOI : 10.1097/MD.0b013e318206af16

B. Dasgupta, F. Borg, N. Hassan, A. L. Barraclough, K. Bourke et al., BSR and BHPR guidelines for the management of giant cell arteritis, Rheumatology, vol.49, issue.8, 2010.
DOI : 10.1093/rheumatology/keq039a

C. Mukhtyar, L. Guillevin, M. Cid, B. Dasgupta, K. De-groot et al., EULAR recommendations for the management of large vessel vasculitis, Annals of the Rheumatic Diseases, vol.68, issue.3, pp.318-341, 2009.
DOI : 10.1136/ard.2008.088351

R. Spiera, H. Mitnick, M. Kupersmith, R. M. Spiera, H. Peterson et al., A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA), Clin Exp Rheumatol, vol.19, issue.5, pp.495-501, 2001.

J. Jover, C. Hernández-garcía, I. Morado, E. Vargas, A. Bañares et al., Combined Treatment of Giant-Cell Arteritis with Methotrexate and Prednisone, Annals of Internal Medicine, vol.134, issue.2, pp.106-120, 2001.
DOI : 10.7326/0003-4819-134-2-200101160-00010

D. Silva, M. Hazleman, and B. , Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study., Annals of the Rheumatic Diseases, vol.45, issue.2, pp.136-144, 1986.
DOI : 10.1136/ard.45.2.136

S. Sciascia, D. Piras, S. Baldovino, A. Russo, C. Naretto et al., Mycophenolate mofetil as steroid-sparing treatment for elderly patients with giant cell arteritis: report of three cases, Aging Clinical and Experimental Research, vol.130, issue.3, pp.273-280
DOI : 10.7326/0003-4819-130-5-199903020-00013

P. Dospinescu, M. Karabayas, D. Kidder, N. Fluck, L. Erwig et al., Mycophenolate Mofetil versus Methotrexate in The Management of Large Vessel Giant Cell Arteritis. Annals of the Rheumatic Diseases, Jul, vol.1575, issue.2, pp.798-799, 2016.

L. Quartuccio, M. Maset, D. Maglio, G. Pontarini, E. Fabris et al., Role of oral cyclophosphamide in the treatment of giant cell arteritis, Rheumatology, vol.51, issue.9, p.2012
DOI : 10.1093/rheumatology/kes127

J. Loock, J. Henes, I. Kötter, T. Witte, P. Lamprecht et al., Treatment of refractory giant cell arteritis with cyclophosphamide:a retrospective analysis of 35 patients from three centres

H. De-boysson, J. Boutemy, C. Creveuil, Y. Ollivier, P. Letellier et al., Is there a place for cyclophosphamide in the treatment of giant-cell arteritis? A case series and systematic review, Seminars in Arthritis and Rheumatism, vol.43, issue.1
DOI : 10.1016/j.semarthrit.2012.12.023

T. Adizie, D. Christidis, C. Dharmapaliah, F. Borg, and B. Dasgupta, Efficacy and tolerability of leflunomide in difficult-to-treat polymyalgia rheumatica and giant cell arteritis: a case series, International Journal of Clinical Practice, vol.60, issue.Suppl 10, pp.906-915, 2012.
DOI : 10.1080/03009740500474537

A. Diamantopoulos, H. Hetland, and G. Myklebust, Leflunomide as a Corticosteroid-Sparing Agent in Giant Cell Arteritis and Polymyalgia Rheumatica: A Case Series, BioMed Research International, vol.33, issue.8, p.120638, 2013.
DOI : 10.1002/art.34356

F. Liozon, E. Vidal, and J. Barrier, Does dapsone have a role in the treatment of temporal arteritis with regard to efficacy and toxicity? Clin Exp Rheumatol, pp.694-699, 1993.

L. Sailler, M. Lapeyre-mestre, L. Geffray, P. Letellier, E. Liozon et al., Adding Hydroxychloroquine to Prednisone Does Not Improve the Outcome in Giant Cell Arteritis: A Double Blind Randomized Controlled Trial, Arthritis Rheum, issue.60, p.1972, 2009.

C. Schaufelberger, H. Möllby, A. Uddhammar, J. Bratt, and E. Nordborg, No additional steroid???sparing effect of cyclosporine A in giant cell arteritis, Scandinavian Journal of Rheumatology, vol.28, issue.20, 2006.
DOI : 10.1080/030097499442504

G. Hoffman, M. Cid, K. Rendt-zagar, P. Merkel, C. Weyand et al., Infliximab for Maintenance of Glucocorticosteroid-Induced Remission of Giant Cell Arteritis, Annals of Internal Medicine, vol.146, issue.9
DOI : 10.7326/0003-4819-146-9-200705010-00004

V. Martinez-taboada, V. Rodriguez-valverde, L. Carreno, J. Lopez-longo, M. Figueroa et al., A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects, Annals of the Rheumatic Diseases, vol.67, issue.5, pp.625-655, 2008.
DOI : 10.1136/ard.2007.082115

D. Emilie, E. Liozon, M. Crevon, C. Lavignac, A. Portier et al., Production of interleukin 6 by granulomas of giant cell arteritis. Human immunology, pp.17-24, 1994.

P. Villiger, S. Adler, S. Kuchen, F. Wermelinger, D. Dan et al., Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial, The Lancet, vol.387, issue.10031, pp.1921-1928, 2016.
DOI : 10.1016/S0140-6736(16)00560-2

J. Stone, K. Tuckwell, S. Dimonaco, M. Klearman, M. Aringer et al., Efficacy and Safety of Tocilizumab in Patients with Giant Cell Arteritis: Primary and Secondary Outcomes from a Phase 3, Arthritis Rheumatol, vol.68, 2016.

A. Bhatia, A. Ell, P. Edwards, and J. , Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis, Annals of the Rheumatic Diseases, vol.64, issue.7, pp.1099-100, 2005.
DOI : 10.1136/ard.2005.036533

C. Langford, D. Cuthbertson, S. Ytterberg, N. Khalidi, P. Monach et al., Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis, Arthritis Rheumatol. 2017, vol.69, issue.4, pp.837-882

R. Conway, O. Neill, L. , O. Flynn, E. Gallagher et al., Ustekinumab for the treatment of refractory giant cell arteritis, Annals of the Rheumatic Diseases, vol.33, issue.8, 2016.
DOI : 10.1002/art.1780330810

K. Ly, J. Stirnemann, E. Liozon, M. Michel, O. Fain et al., Interleukin-1 blockade in refractory giant cell arteritis, Joint Bone Spine, vol.81, issue.1, pp.76-84, 2014.
DOI : 10.1016/j.jbspin.2013.06.004

C. Salvarani, F. Cantini, and G. Hunder, Polymyalgia rheumatica and giant-cell arteritis, Lancet, 2008.

G. Tomasson, C. Peloquin, A. Mohammad, T. Love, Y. Zhang et al., Risk for Cardiovascular Disease Early and Late After a Diagnosis of Giant-Cell Arteritis, Annals of Internal Medicine, vol.160, issue.2, pp.73-80, 2014.
DOI : 10.7326/M12-3046

N. Amiri, D. Vera, M. Choi, H. Sayre, E. Aviña-zubieta et al., Increased risk of cardiovascular disease in giant cell arteritis: a general population???based study, Rheumatology, vol.55, issue.1, p.2016
DOI : 10.1093/rheumatology/kev262

M. Lee, S. Smith, A. Galor, and G. Hoffman, Antiplatelet and anticoagulant therapy in patients with giant cell arteritis, Arthritis & Rheumatism, vol.41, issue.10, pp.3306-3315, 2006.
DOI : 10.1002/art.1780330810

V. Martínez-taboada, M. López-hoyos, J. Narvaez, and P. Muñoz-cacho, Effect of antiplatelet/anticoagulant therapy on severe ischemic complications in patients with giant cell arteritis: A cumulative meta-analysis, Autoimmunity Reviews, vol.13, issue.8, pp.788-94, 2014.
DOI : 10.1016/j.autrev.2014.02.006

A. Souza, . De, K. Okamoto, F. Abrantes, B. Schau et al., Giant cell arteritis: a multicenter observational study in Brazil, Clinics, vol.68, issue.3, pp.317-339, 2013.
DOI : 10.6061/clinics/2013(03)OA06

A. García-martínez, J. Hernández-rodríguez, J. Grau, and M. Cid, Treatment with statins does not exhibit a clinically relevant corticosteroid-sparing effect in patients with giant cell arteritis, Arthritis Care & Research, vol.22, issue.4, pp.674-682, 2004.
DOI : 10.1161/01.ATV.0000022694.16328.CC

J. Narvaez, B. Bernad, J. Nolla, and J. Valverde, Statin therapy does not seem to benefit giant cell arteritis. Semin Arthritis Rheum, pp.322-329, 2007.

J. Schmidt, T. Kermani, F. Muratore, C. Crowson, E. Matteson et al., Statin Use in Giant Cell Arteritis: A Retrospective Study, The Journal of Rheumatology, vol.40, issue.6, pp.910-915
DOI : 10.3899/jrheum.121150

G. Pugnet, L. Sailler, R. Bourrel, J. Montastruc, and M. Lapeyre-mestre, Is Statin Exposure Associated with Occurrence or Better Outcome in Giant Cell Arteritis? Results from a French Population-based Study, The Journal of Rheumatology, vol.42, issue.2, pp.316-338, 2015.
DOI : 10.3899/jrheum.140906

M. Alba, A. García-martínez, S. Prieto-gonzález, G. Espígol-frigolé, M. Butjosa et al., Treatment with angiotensin II receptor blockers is associated with prolonged relapse-free survival, lower relapse rate, and corticosteroid-sparing effect in patients with giant cell arteritis, Seminars in Arthritis and Rheumatism, vol.43, issue.6, pp.772-779, 2014.
DOI : 10.1016/j.semarthrit.2013.10.009

C. Labarca, M. Koster, C. Crowson, A. Makol, S. Ytterberg et al., Predictors of relapse and treatment outcomes in biopsy-proven giant cell arteritis: a retrospective cohort study, Rheumatology, vol.55, issue.2, pp.347-56
DOI : 10.1093/rheumatology/kev348

E. Liozon, P. Roblot, D. Paire, V. Loustaud, F. Liozon et al., Anticardiolipin antibody levels predict flares and relapses in patients with giant-cell (temporal) arteritis. A longitudinal study of 58 biopsy-proven cases, Rheumatology, vol.39, issue.10, pp.1089-94, 2000.
DOI : 10.1093/rheumatology/39.10.1089

J. Hernández-rodríguez, A. García-martínez, J. Casademont, X. Filella, M. Esteban et al., A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis, Arthritis Care & Research, vol.44, issue.Suppl 9, pp.29-35, 2002.
DOI : 10.1002/1529-0131(200105)44:5<1149::AID-ANR197>3.0.CO;2-F

E. Hachulla, V. Boivin, U. Pasturel-michon, A. Fauchais, J. Bouroz-joly et al., Prognostic factors and long-term evolution in a cohort of 133 patients with giant cell arteritis, Clin Exp Rheumatol, vol.19, issue.2, pp.171-177, 2001.

C. Hill, R. Black, J. Nossent, C. Ruediger, L. Nguyen et al., Risk of mortality in patients with giant cell arteritis: A systematic review and meta-analysis. Semin Arthritis Rheum, Feb, vol.46, issue.4, pp.513-522, 2017.

T. Kermani, K. Warrington, C. Crowson, S. Ytterberg, G. Hunder et al., Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis, Annals of the Rheumatic Diseases, vol.18, issue.12, pp.1989-94, 2013.
DOI : 10.1093/ije/18.4.836

J. Kelley, Doppler Ultrasound Flow Detector Used in Temporal Artery Biopsy, Archives of Ophthalmology, vol.96, issue.5, pp.845-851, 1978.
DOI : 10.1001/archopht.1978.03910050451010

H. Maeda, N. Handa, M. Matsumoto, H. Hougaku, S. Ogawa et al., Carotid lesions detected by B-mode ultrasonography in Takayasu's arteritis: ???Macaroni sign??? as an indicator of the disease, Ultrasound in Medicine & Biology, vol.17, issue.7, pp.695-701, 1991.
DOI : 10.1016/0301-5629(91)90101-2

E. Ball, S. Walsh, T. Tang, R. Gohil, and J. Clarke, Role of ultrasonography in the diagnosis of temporal arteritis, British Journal of Surgery, vol.281, issue.Suppl 20, pp.1765-71, 2010.
DOI : 10.1038/sj.eye.6700677

M. Karahaliou, G. Vaiopoulos, S. Papaspyrou, M. Kanakis, K. Revenas et al., Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis, Arthritis Research & Therapy, vol.8, issue.4, p.116, 2006.
DOI : 10.1186/ar2003

M. Aschwanden, T. Daikeler, F. Kesten, T. Baldi, D. Benz et al., Temporal Artery Compression Sign - A Novel Ultrasound Finding for the Diagnosis of Giant Cell Arteritis, Ultraschall in der Medizin - European Journal of Ultrasound, vol.34, issue.01, pp.47-50, 2013.
DOI : 10.1055/s-0032-1312821

F. Muratore, L. Boiardi, G. Restuccia, P. Macchioni, G. Pazzola et al., Comparison between colour duplex sonography findings and different histological patterns of temporal artery, Rheumatology, vol.52, issue.12, pp.2268-74, 2013.
DOI : 10.1093/rheumatology/ket258

A. Diamantopoulos, G. Haugeberg, H. Hetland, D. Soldal, R. Bie et al., Diagnostic Value of Color Doppler Ultrasonography of Temporal Arteries and Large Vessels in Giant Cell Arteritis: A Consecutive Case Series, Arthritis Care & Research, vol.41, issue.Suppl 20, pp.113-122
DOI : 10.3109/03009742.2011.641584

M. Czihal, F. Tatò, A. Rademacher, P. Kuhlencordt, H. Schulze-koops et al., Involvement of the Femoropopliteal Arteries in Giant Cell Arteritis: Clinical and Color Duplex Sonography, The Journal of Rheumatology, vol.39, issue.2, pp.314-335, 2012.
DOI : 10.3899/jrheum.110566

C. Agard, M. Hamidou, L. Said, T. Ponge, J. Connault et al., Screening of abdominal aortic involvement using Doppler sonography in active giant cell (temporal) arteritis at the time of diagnosis. A prospective study of 30 patients]. La Revue de Médecine Interne, 2007.

A. García-martínez, P. Arguis, S. Prieto-gonzález, G. Espígol-frigolé, M. Alba et al., Prospective long term follow-up of a cohort of patients with giant cell arteritis screened for aortic structural damage (aneurysm or dilatation), Annals of the Rheumatic Diseases, vol.38, issue.suppl, 2014.
DOI : 10.3899/jrheum.110275

P. Patil, M. Williams, W. Maw, K. Achilleos, S. Elsideeg et al., Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study, Clin Exp Rheumatol. 2015, vol.33, issue.2, pp.103-109

A. Diamantopoulos, G. Haugeberg, A. Lindland, and G. Myklebust, The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis?, Rheumatology, vol.55, issue.1, pp.66-70, 2016.
DOI : 10.1093/rheumatology/kev289

S. Monti, A. Floris, C. Ponte, W. Schmidt, A. Diamantopoulos et al., The use of ultrasound to assess giant cell arteritis: review of the current evidence and practical guide for the rheumatologist, Rheumatology, p.2017
DOI : 10.1093/rheumatology/kex173

K. Stengl, R. Buchert, H. Bauknecht, and J. Sobesky, A hidden giant: Wallenberg syndrome and aortal wall thickening as an atypical presentation of a giant cell arteritis, Case Reports, vol.2013, issue.mar01 1, pp.2012006994-2012006998, 2013.
DOI : 10.1136/bcr-2012-006994

M. Aschwanden, F. Kesten, M. Stern, C. Thalhammer, U. Walker et al., Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions, Annals of the Rheumatic Diseases, vol.69, issue.7, pp.1356-1365, 2010.
DOI : 10.1136/ard.2009.122135

P. López, J. , S. Laqué, R. , B. Gil et al., Colour-duplex ultrasonography of the temporal and ophthalmic arteries in the diagnosis and follow-up of giant cell arteritis, Clin Exp Rheumatol, vol.27, issue.1, pp.77-82, 2009.

H. Habib, A. Essa, and A. Hassan, Color duplex ultrasonography of temporal arteries: role in diagnosis and follow-up of suspected cases of temporal arteritis, Clinical Rheumatology, vol.28, issue.2, p.2012
DOI : 10.1080/03009749950155373

C. Hauenstein, R. M. Geiger, J. Markl, M. Hetzel, A. Treszl et al., Effects of early corticosteroid treatment on magnetic resonance imaging and ultrasonography findings in giant cell arteritis, Rheumatology, vol.51, issue.11, pp.1999-2003, 2012.
DOI : 10.1093/rheumatology/kes153

L. Santoro, D. Onofrio, F. Bernardi, S. Gremese, E. Ferraccioli et al., Temporal ultrasonography findings in temporal arteritis: early disappearance of halo sign after only 2 days of steroid treatment Díaz-Llopis M. Doppler ultrasound and giant cell arteritis, 622. 165. Suelves AM, pp.1383-1387, 2010.

G. Nesher, R. Nesher, M. Mates, M. Sonnenblick, and G. Breuer, Giant Cell Arteritis, Clin Exp Rheumatol, 2008.
DOI : 10.1007/978-1-60327-285-8_13

H. De-boysson, M. Lambert, E. Liozon, J. Boutemy, G. Maigné et al., Giant-cell arteritis without cranial manifestations, Medicine, vol.95, issue.26, 2016.
DOI : 10.1097/MD.0000000000003818

W. Schmidt, A. Krause, B. Schicke, J. Kuchenbecker, and E. Gromnica-ihle, Do temporal artery duplex ultrasound findings correlate with ophthalmic complications in giant cell arteritis? Rheumatology (Oxford), pp.383-388, 2009.

V. Schäfer, A. Juche, R. S. Krause, A. Schmidt, and W. , Ultrasound cut-off values for intimamedia thickness of temporal, facial and axillary arteries in giant cell arteritis, Rheumatology

D. Makkuni, A. Bharadwaj, K. Wolfe, S. Payne, A. Hutchings et al., Is intimal hyperplasia a marker of neuro-ophthalmic complications of giant cell arteritis? Rheumatology (Oxford), 2008.

D. Chatelain, P. Duhaut, J. Schmidt, R. Loire, S. Bosshard et al., Pathological features of temporal arteries in patients with giant cell arteritis presenting with permanent visual loss, Annals of the Rheumatic Diseases, vol.68, issue.1, pp.84-92, 2009.
DOI : 10.1136/ard.2007.084947

C. Salvarani, L. Cimino, P. Macchioni, D. Consonni, F. Cantini et al., Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis. Arthritis Rheum, pp.293-300, 2005.

G. Nesher, M. Sonnenblick, and Y. Friedlander, Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients, J Rheumatol, vol.21, issue.7, pp.1283-1289, 1994.

M. Gonzalez-gay, A. Piñeiro, A. Gomez-gigirey, C. Garcia-porrua, R. Pego-reigosa et al., Influence of Traditional Risk Factors of Atherosclerosis in the Development of Severe Ischemic Complications in Giant Cell Arteritis, Medicine, vol.83, issue.6, pp.342-349, 2004.
DOI : 10.1097/01.md.0000145369.25558.b5

L. Pfenninger, A. Horst, G. Stuckmann, R. Flury, and J. Stürmer, Comparison of Histopathological Findings with Duplex Sonography of the Temporal Arteries in Suspected Giant Cell Arteritis, Klinische Monatsbl??tter f??r Augenheilkunde, vol.229, issue.04, pp.369-73
DOI : 10.1055/s-0031-1299232

G. Germano, F. Muratore, L. Cimino, G. Lo, A. Possemato et al., Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study, Rheumatology, vol.54, issue.3, pp.400-404, 2015.
DOI : 10.1093/rheumatology/keu241

C. Salvarani, M. Silingardi, A. Ghirarduzzi, S. Lo, G. Macchioni et al., Is Duplex Ultrasonography Useful for the Diagnosis of Giant-Cell Arteritis?, Annals of Internal Medicine, vol.137, issue.4, pp.232-240, 2002.
DOI : 10.7326/0003-4819-137-4-200208200-00006

J. Richter, O. Sander, and M. Schneider, Causes of Cardiovascular Ischemic Events in Giant Cell Arteritis, The Journal of Rheumatology, vol.43, issue.12, pp.2092-2095
DOI : 10.3899/jrheum.161237